Report Description
Canada Diabetes Care Devices Market Outlook 2031:
The Canada diabetes care devices market size was valued at USD 1.91 Billion in 2022 and is projected to reach USD 2.96 Billion by 2031, expanding at a CAGR of 4.98% during the forecast period 2023 - 2031. The growth of the market is attributed to increasing prevalence of diabetes in low- and middle-income countries.
A person’s body with diabetes commonly produce almost no insulin in pancreas. Obesity and inactive lifestyle are the major cause of diabetes. According to the data published by the Conference Board of Canada, around 2 million people in Canada are found with diabetes condition, which means one in 16 people have diabetes. As per the study conducted by Diabetes Canada, 12.1% or around 5 million of Canada-based population can be diagnosed with diabetes. Type-1 and type-2 are the two types of diabetes.
Canada Diabetes Care Devices Market Trends Drivers, Restraints and Opportunities
- The rise in obesity population and prevalence of unhealthy lifestyle are some of the major factors that can propel the market growth.
- Increasing government funding for diabetes management and presence of reimbursement policies can spur the growth of the market.
- Technological advancements and increasing requirement for faster and safer diagnosis and treatment of diabetes are the key factors that can support the industry growth during the forecast period.
Scope of the Canada Diabetes Care Devices Market Report
The report on the Canada Diabetes Care Devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report
Attributes
|
Details
|
Report Title
|
Canada Diabetes Care Devices Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
Base Year
|
2022
|
Historic Data
|
2016–2021
|
Forecast Period
|
2023–2031
|
Segmentation
|
Type of Management Devices (Insulin Pumps, Insulin Syringes, Insulin Disposable Pens, Insulin Cartridges in Reusable Pens, and Insulin Jet Injectors) and Monitoring Devices (Self-monitoring Blood Glucose and Continuous Glucose Monitoring)
|
Country
|
Canada
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
Key Players Covered in the Report
|
Dexcom; Medtronic; Novo Nordisk A/S; F. Hoffmann-La Roche AG; Abbott Diabetes Care
|
Canada Diabetes Care Devices Market Segment Insights
Diabetes management mobile applications segment is projected to exhibit high CAGR
On the basis of monitoring devices, the market is segmented into blood glucose monitoring systems, insulin delivery devices, and diabetes management mobile applications. The diabetes management mobile applications segment is accepted to grow at high rate during forecast period.
Rising use of mobile phones to manage the diabetes is driving the market growth. On the other hand, the blood glucose monitoring systems segment is estimated to account a major market share in the coming years. Increasing demand for glucose monitoring devices to self-monitor the diabetes is propelling the segment growth.
Insulin syringes segment to account a major market share
Based on type of management devices, the Canada diabetes care devices market is divided into insulin pumps, insulin syringes, insulin disposable pens, insulin cartridges in reusable pens, insulin jet injectors. The insulin syringes segment is anticipated to account for a major market share during the forecast period. The cost-effectiveness and easy availability of insulin syringes are some of the factors driving the growth of the market segment.
The insulin jet injectors segment is anticipated to exhibit a high CAGR during the forecast period. Insulin jet injectors are claimed to be relatively-free, which is spurring the demand for them among diabetic patients.
Segments
The Canada diabetes care devices market has been segmented on the basis of:
Type of Management Devices
- Insulin Jet Injectors
- Insulin Pumps
- Insulin Syringes
- Insulin Disposable Pens
- Insulin Cartridges in Reusable Pens
Monitoring Devices
- Self-monitoring Blood Glucose
- Continuous Glucose Monitoring
Country
Key Players
Competitive Landscape
Key players competing in the Canada Diabetes Care Devices Market are Dexcom; Medtronic; Novo Nordisk A/S; F. Hoffmann-La Roche AG; Abbott Diabetes Care. Companies are focusing on partnering with local manufacturers and collaborating with other industry players to expand their market share. Constant innovations are made by the manufacturers so that they can still remain into the market.
In April 2021, Medtronic announced the launch of the Medtronic Extended Infusion set in selected Europe-based countries. The set can be worn for up to seven days. It claims that it maintains the insulin flow and stability. However, the set is still in investigational use in the US.
In December 2020, Abbott introduced FreeStyle Libre 2, a sensor-based glucose monitoring technology, which has been already approved by Health Canada for individuals above 4 years. The technology allows the patients to get real-time alerts, which eliminates the use of painful needles.
Table Of Content
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Diabetes Care Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Diabetes Care Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Diabetes Care Devices Market - Supply Chain
4.5. Global Diabetes Care Devices Market Forecast
4.5.1. Diabetes Care Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Diabetes Care Devices Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Diabetes Care Devices Market Absolute $ Opportunity
5. Global Diabetes Care Devices Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Diabetes Care Devices Market Size and Volume Forecast by Types
5.3.1. Insulin Jet Injectors
5.3.2.
Insulin Pumps
5.3.3.
Insulin Syringes
5.3.4.
Insulin Disposable Pens
5.3.5.
Insulin Cartridges in Reusable Pens
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Diabetes Care Devices Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Diabetes Care Devices Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Diabetes Care Devices Demand Share Forecast, 2019-2026
7. North America Diabetes Care Devices Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Diabetes Care Devices Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Diabetes Care Devices Market Size and Volume Forecast by Types
7.4.1. Insulin Jet Injectors
7.4.2.
Insulin Pumps
7.4.3.
Insulin Syringes
7.4.4.
Insulin Disposable Pens
7.4.5.
Insulin Cartridges in Reusable Pens
7.5. Basis Point Share (BPS) Analysis by Types
7.6. Y-o-Y Growth Projections by Types
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Diabetes Care Devices Demand Share Forecast, 2019-2026
8. Latin America Diabetes Care Devices Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Diabetes Care Devices Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Diabetes Care Devices Market Size and Volume Forecast by Types
8.4.1. Insulin Jet Injectors
8.4.2.
Insulin Pumps
8.4.3.
Insulin Syringes
8.4.4.
Insulin Disposable Pens
8.4.5.
Insulin Cartridges in Reusable Pens
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Diabetes Care Devices Demand Share Forecast, 2019-2026
9. Europe Diabetes Care Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Diabetes Care Devices Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Diabetes Care Devices Market Size and Volume Forecast by Types
9.4.1. Insulin Jet Injectors
9.4.2.
Insulin Pumps
9.4.3.
Insulin Syringes
9.4.4.
Insulin Disposable Pens
9.4.5.
Insulin Cartridges in Reusable Pens
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Diabetes Care Devices Demand Share Forecast, 2019-2026
10. Asia Pacific Diabetes Care Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Diabetes Care Devices Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Diabetes Care Devices Market Size and Volume Forecast by Types
10.4.1. Insulin Jet Injectors
10.4.2.
Insulin Pumps
10.4.3.
Insulin Syringes
10.4.4.
Insulin Disposable Pens
10.4.5.
Insulin Cartridges in Reusable Pens
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Diabetes Care Devices Demand Share Forecast, 2019-2026
11. Middle East & Africa Diabetes Care Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Diabetes Care Devices Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Diabetes Care Devices Market Size and Volume Forecast by Types
11.4.1. Insulin Jet Injectors
11.4.2.
Insulin Pumps
11.4.3.
Insulin Syringes
11.4.4.
Insulin Disposable Pens
11.4.5.
Insulin Cartridges in Reusable Pens
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Diabetes Care Devices Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Diabetes Care Devices Market: Market Share Analysis
12.2. Diabetes Care Devices Distributors and Customers
12.3. Diabetes Care Devices Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Dexcom
12.4.2.
Medtronic
12.4.3.
Novo Nordisk A/S
12.4.4.
F. Hoffmann-La Roche AG
12.4.5.
Abbott Diabetes Care